Osigu is a technology company.
Osigu is the first fully digital, AI-powered end-to-end revenue cycle and claims management platform in Latin America, bridging the gap between healthcare and fintech.
Osigu has raised $10.0M across 1 funding round.
Osigu has raised $10.0M in total across 1 funding round.
Osigu has raised $10.0M in total across 1 funding round.
Osigu's investors include Eos Venture Partners, MS&AD Ventures, Joseph Malchow.
Osigu is a technology company that provides an AI-powered, fully digital platform for end-to-end revenue cycle and claims management specifically tailored to the healthcare sector in Latin America. Its platform automates and streamlines the entire healthcare payment process, connecting providers, payers, and patients to reduce inefficiencies, minimize fraud, and accelerate reimbursements. By modernizing legacy systems with intelligent workflows and cloud-based technology, Osigu addresses critical financial and operational challenges in healthcare, enabling faster, more transparent, and reliable transactions. The company serves healthcare providers, payers, and patients, aiming to improve financial health and operational efficiency across the healthcare ecosystem. Osigu has demonstrated growth momentum through strategic acquisitions and partnerships, including a notable collaboration with J.P. Morgan to enhance real-time healthcare payments[1][2][4][5].
Osigu was founded in 2015 and is headquartered in Miami, Florida. The company was established by Fernando Botrán, who serves as CEO and brings prior leadership experience from his role as CEO at Giftop. The idea for Osigu emerged from the need to bridge the gap between healthcare and fintech by automating and digitizing critical healthcare financial processes that were traditionally manual, fragmented, and inefficient. Early traction came from developing a platform that enables seamless data exchange between payers and providers through a single API integration, eliminating tedious manual processes such as phone calls and paper forms. This innovation helped reduce administrative costs and fraud while improving patient access to care. Osigu’s growth has been supported by investors such as Jose Vargas, ATW Partners, and IDC Ventures, and it has raised over $8 million in funding[1][2][3].
Osigu rides the growing trend of digital transformation in healthcare finance, particularly the convergence of healthcare and fintech. The timing is critical as Latin America’s healthcare systems face increasing pressure to improve operational efficiency, reduce fraud, and accelerate payments amid rising costs and demand for better patient experiences. Market forces such as regulatory changes, increased adoption of cloud technologies, and the need for interoperability favor Osigu’s platform. By automating and digitizing revenue cycle management, Osigu not only improves financial operations for providers and payers but also enhances patient access and satisfaction. Its role as a bridge between healthcare and fintech positions it as a key enabler of the financial transformation in Latin America’s healthcare ecosystem, influencing broader adoption of AI and SaaS solutions in the sector[2][4][5].
Looking ahead, Osigu is poised to expand its footprint in Latin America through further acquisitions and strategic partnerships, continuing to refine its AI-driven platform to address evolving healthcare payment challenges. Trends such as increased demand for real-time payments, greater regulatory scrutiny on fraud, and the push for interoperability will shape its journey. Osigu’s influence is likely to grow as it helps healthcare providers and payers transition from legacy systems to fully digital, automated workflows, ultimately contributing to a more efficient and financially sustainable healthcare ecosystem in the region. Its ongoing collaboration with financial institutions and expansion into new markets will be critical to maintaining momentum and scaling impact[1][2][5].
Osigu has raised $10.0M across 1 funding round. Most recently, it raised $10.0M Series B in August 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2025 | $10.0M Series B | Eos Venture Partners, MS&AD Ventures, Joseph Malchow |